OTCM
NUMIF
Market cap11mUSD
Jul 09, Last price
0.03USD
1D
-14.53%
1Q
233.33%
Name
Numinus Wellness Inc
Chart & Performance
P/E
—
P/S
3.27
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
4m
+11.08%
Net income
-20m
L-35.08%
CFO
-12m
L-45.37%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Numinus Wellness Inc. is dedicated to pioneering and delivering psychedelic-assisted psychotherapy, with the overarching goal of reshaping the mental healthcare landscape. The company's operations are segmented into two primary divisions: Salvation Botanicals and Numinus Health. Salvation Botanicals provides comprehensive laboratory services focused on psychedelics, encompassing cultivation, analytical testing, product research and development, and various ancillary supports. Additionally, this division offers both full-suite and bespoke testing for cannabis products. Numinus Health concentrates on promoting healing, connection, and personal growth through a range of supportive therapies and advanced technologies. This division specializes in addressing mental health challenges and substance abuse, delivering services including psychotherapy, counselling, neurofeedback, physiotherapy, and other therapeutic modalities. Furthermore, Numinus Health equips practitioners with vital training, facilities, and operational resources. The company's headquarters are situated in Vancouver, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑07 | 2016‑07 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||